Efficacy and Safety for Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

NCT02379663 Phase 4 COMPLETED

This prospective study compares an oral direct factor Xa inhibitor with LMWH for thromboprophylaxis in the patients undergoing THA.

Details

Lead sponsor	Samsung Medical Center
Phase	Phase 4
Status	COMPLETED
Enrolment	639
Start date	2012-01
Completion	2013-01

Conditions

• Osteoarthritis, Hip
• Femur Head Necrosis
• Femoral Neck Fractures

Interventions

• Rivaroxaban
• Enoxaparin
• Normal saline

Primary outcomes

• Major wound complication — 2 weeks
  hematoma : size, site woozing : frequency, amount, dressing change count infection : culture